WELL Health Technologies Corp. (WELL:CA) Q4 2025 Earnings Call Transcript
seekingalpha.com
Want to monitor EYPT?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor EYPTEYP-1901 is a potential twice-yearly sustained delivery intravitreal anti-VEGF treatment for wet age-related macular degeneration.